Indian pharmaceutical stocks witnessed a decline as a result of the recent threat made by Donald Trump regarding tariffs on pharmaceutical imports. The Nifty Pharma index dropped by 1.7%, impacting leading companies such as Gland Pharma and Sun Pharma. Trump’s remarks emphasized the push to encourage pharmaceutical firms to relocate their manufacturing operations to the United States using tariffs, affecting India’s significant generic drug exports to the US.